Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. 2000

E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
Department of Internal Medicine and Medical Therapy, Chair of Geriatrics, University of Pavia, P.zza Borromeo 2, 27100, Pavia, Italy. ferrari@unipv.it

The simultaneous evaluation of the circadian rhythm of plasma melatonin and ACTH and of serum cortisol and DHEAS represents a clinically reliable tool to appreciate the neuroendocrine changes occurring in physiological and pathological brain aging.A selective impairment of the nocturnal melatonin secretion has been observed in elderly subjects, being significantly related either to the age or to the severity of dementia. A significant increase of serum cortisol levels during evening- and night-times was found in elderly subjects, particularly if demented, when compared to young controls. Besides, both the circadian amplitude of cortisol rhythm and the nocturnal cortisol increase were significantly reduced in relation either to age or to cognitive impairment. By comparison to vascular dementia, patients with Alzheimer's disease exhibited the highest cortisol concentrations throughout the 24h. The sensitivity of the hypothalamic-pituitary-adrenal axis to the steroid feedback was significantly impaired in old subjects and particularly in the demented ones. The serum DHEAS levels were significantly lower in elderly subjects and even more in demented patients than in young controls. Consequently, a significant increase of the cortisol/DHEAS molar ratio was evident when going from young controls to healthy elderly subjects and to demented patients. In conclusion, the aging process affects many neuroendocrine functions resulting in subtle but clinically relevant consequences; the occurrence of senile dementia seems to play an additive role.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010870 Pineal Gland A light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other BIOGENIC AMINES and NEUROPEPTIDES. Epiphysis Cerebri,Pineal Body,Corpus Pineale,Gland, Pineal,Pineal Bodies,Pineal Glands
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic

Related Publications

E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
January 1994, Chronobiologia,
E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
January 1997, Aging (Milan, Italy),
E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
January 1987, Advances in biochemical psychopharmacology,
E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
January 1974, Nihon rinsho. Japanese journal of clinical medicine,
E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
January 1972, Canadian Psychiatric Association journal,
E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
July 1985, Nihon rinsho. Japanese journal of clinical medicine,
E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
January 1985, Annals of the New York Academy of Sciences,
E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
January 1981, Progress in neuro-psychopharmacology,
E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
March 1984, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
E Ferrari, and A Arcaini, and R Gornati, and L Pelanconi, and L Cravello, and M Fioravanti, and S B Solerte, and F Magri
January 1982, Acta neurologica Scandinavica,
Copied contents to your clipboard!